Surgical Site Infection Prevention Collaborative MCIC March 2006.

73
Surgical Site Infection Prevention Collaborative MCIC March 2006

Transcript of Surgical Site Infection Prevention Collaborative MCIC March 2006.

Page 1: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Surgical Site Infection Prevention Collaborative

MCIC March 2006

Page 2: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Background: NNIS• National Nosocomial Infection Surveillance (NNIS)

System– CDC program that reports aggregated surveillance data

from ~300 US hospitals

– Standard case-finding (by ICD-9 code), definitions for infection, and risk-stratification methodology

– Pooled mean and standard deviation reported for surgical procedures, including craniotomy, laminectomy, spinal fusion, C-section, and CABG

Page 3: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Background: Methodology• HEIC surveillance methodology

– Monthly denominator data from case-mix data base (all NNIS procedures by ICD-9 code)

– Complete chart review of all procedures performed to assess for infection

– Risk stratification• Length of procedure (1 point)• ASA score (1 point)• Wound class (assuming all procedures are clean because CANNOT get

wound class)

– Generation and distribution of standardized rates quarterly or semi-annually (if denominator < 50/quarter)

Page 4: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Background: Reporting

• HEIC reporting strategies– Rates with NNIS benchmarking – Weekly evaluation of numbers of infections

(includes non-NNIS procedures)

Page 5: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Present your local NNIS infection data here

Page 6: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Surgical Site Infections

GOALS

• Define and identify risk factors for SSI

• Discuss strategies for prevention

• Discuss antibiotic prophylaxis principles

Pamela A. Lipsett, MDProfessorDepartments of Surgery,Anesthesiology,

Critical Care Medicine, Nursing Johns Hopkins University Schools of Medicine

and Nursing

Page 7: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Proportion of Adverse EventsMost Frequent Categories

0%

5%

10%

15%

20%

25%

Drug-related

Woundinfect.

Tech.comp.

Latecomp.

Diag.mishap

Therap.mishap

Nontech.comp.

Proc.related

Brennan. N Engl J Med. 1991;324:370-376

Non-surgical

Surgical

Page 8: Surgical Site Infection Prevention Collaborative MCIC March 2006.

INTRODUCTION

• 40 million operations annually

• 20% experience infection

• Surgical site infections (SSI) prolong hospital stay by 6.5 to 7.4 days and comprise 42% of extra charges

Page 9: Surgical Site Infection Prevention Collaborative MCIC March 2006.

SSI:RISK FACTORSINTRINSIC-PATIENT RELATED

• Age• Nutritional status• Diabetes• Smoking• Obesity• Remote infections

• Endogenous mucosal microorganisms

• Altered immune system

• Preoperative stay-severity of illness

Page 10: Surgical Site Infection Prevention Collaborative MCIC March 2006.

SSI:RISK FACTORSEXTRINSIC-

OPERATION RELATED

• Duration of surgical scrub

• Skin antisepsis• Preop shaving• Preop skin prep• Surgical attire• Sterile draping• Surgical technique

• Duration of operation

• Prophylaxis• Ventilation• Sterilization of

equipment• Wound class• Drains

Page 11: Surgical Site Infection Prevention Collaborative MCIC March 2006.

NON-ANTIBIOTIC FACTORS

• Length of pre-operative stay

• Pre-operative shaving• Length of operation• Use of abdominal

drains

• Pre-operative showering

• Presence of remote infections

• Normothermia• Increased oxygenation• Glucose control

Page 12: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Temperature and SSI Following Colectomy

• Mechanical bowel prep

• Parenteral antibiotics at induction x 4 d

• Standard anesthetic-isoflurane

• Randomized after inductionT>36.5 º or T>34.5 º

• Supplemental O2 in PACU x 3h

• Aggressive fluid resuscitation

Kurz. NEJM 1996;334:1209

Page 13: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Temperature and SSI Following Colectomy

Normo (104) Hypo(96) P

SSI 6 18 .009

Collagen 328 254 .04

Time to eat 5.6d 6.5d <.006

Kurz. NEJM 1996;334:1209

Page 14: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Hyperglycemia and Infection RiskAbdominal and Cardiovascular Operations

Glucose POD#1<220 mg% >220 mg%

Any Infection 12% 31%

“Serious” Infection 5.7-fold increase for any glucose > 220 mg%

Pomposelli. JPEN 1998;22:77

Page 15: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Diabetes, Glucose Control, and SSIsAfter Median Sternotomy

0

5

10

15

20

<200 200-249 250-299 >300

% In

fect

ion

s

Latham. ICHE 2001; 22: 607-12

Page 16: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Insulin Treatment in SICU Patients

Treatment Group

Conventional Intensive

Death in ICU 63/783 (8%) 35/765 (5%)

Van den Berghe. NEJM 2001;345:1359

Page 17: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Preoperative Recommendations: Category 1A

• If hair is removed, remove immediately before the operation, preferably with electric clippers

Page 18: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Influence of Shaving on SSI

No HairGroup Removal Depilatory Shaved

Number 155 153 246

Infection rate 0.6% 0.6% 5.6%

Seropian. Am J Surg 1971; 121: 251

Page 19: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Shaving, Clipping and SSI

Cruse. Arch Surg 1973; 107: 206

% Infected

0

0.5

1

1.5

2

2.5

Shave Clip Neither

Page 20: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Hair Removal Techniques and SSI

% Infection

0

4

8

12

PMRazor

AMRazor

PMClipper

AMClipper

Clean

Clean-Contam

Alexander. Arch Surg 1983; 118: 347

Page 21: Surgical Site Infection Prevention Collaborative MCIC March 2006.

GUIDELINES FOR ANTIBIOTIC PROPHYLAXIS

1. The procedure should carry a significant risk of infection and/or cause significant bacterial contamination.

Page 22: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Relative Benefit from Antibiotic Surgical Prophylaxis

Operation Prophylaxis (%) Placebo (%) NNT*Colon 4-12 24-48 3-5Other (mixed) GI 4-6 15-29 4-9Vascular 1-4 7-17 10-17Cardiac 3-9 44-49 2-3Hysterectomy 1-16 18-38 3-6Craniotomy 0.5-3 4-12 9-29Total joint 0.5-1 2-9 12-100Breast & hernia ops 3.5 5.2 58

* Number Needed to Treat

Page 23: Surgical Site Infection Prevention Collaborative MCIC March 2006.

GUIDELINES FOR ANTIBIOTIC PROPHYLAXIS

2.The antibiotic selected must be active against the major contaminating organisms and should have previously been shown to be effective prophylaxis.

It is NOT necessary to cover ALL organisms present.

Page 24: Surgical Site Infection Prevention Collaborative MCIC March 2006.

GUIDELINES FOR ANTIBIOTIC PROPHYLAXIS

3. The antibiotic chosen must achieve concentrations higher than the minimal inhibitory concentration (MIC) of the suspected pathogens in the wound site at the time of incision.

Page 25: Surgical Site Infection Prevention Collaborative MCIC March 2006.

GUIDELINES FOR ANTIBIOTIC PROPHYLAXIS

4. The shortest possible course of the most effective least toxic antibiotic must be used for prophylaxis. Must consider distribution and half-life of individual agents.

Page 26: Surgical Site Infection Prevention Collaborative MCIC March 2006.

GUIDELINES FOR ANTIBIOTIC PROPHYLAXIS

5. The newer broader spectrum agents must be saved for therapy of resistant organisms and should not be used for prophylaxis.

Page 27: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Antimicrobial Prophylaxis: Category IB

• Do not routinely use vancomycin for antimicrobial prophylaxis

Page 28: Surgical Site Infection Prevention Collaborative MCIC March 2006.

WHEN (TIMING) OF PROPHYLACTIC AGENTS

• Antibiotic levels of the individual agents must be higher than the MIC at the time of incision

• Individual agents must be considered– Cefazolin has a Vd of 10-12 L can can be

pushed within minutes of incision– Additional doses dependent on half-life and

blood loss

Page 29: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Timing Analysis

01020304050607080

90100

Early Optimal Late Never

1985

1988

1992

1993

1994-96

Burke JP. CID. 2001;33;s78-s82

Page 30: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Appropriate Use:LDSYear # Operations SSI (%) Inappropriate

Prophylaxis (%)

1996 976 17 (1.7) 6 (35)

1997 1035 30 (2.9) 6 (20)

1998 963 12 (1.2) 1 (8)

1999 932 16 (1.7) 0

Burke JP. CID. 2001;33;s78-s82

Page 31: Surgical Site Infection Prevention Collaborative MCIC March 2006.

2.7 1.24.3

20.3

56

2.8 1.4 0.9 0.9

9.6

0

10

20

30

40

50

60

Minutes Before or After Incision

Per

cen

t

Inc

isio

n

Antibiotic Timing Related to Incision

Bratzler DW, Houck PM, et al. Arch Surg 2005:140:174-182

Page 32: Surgical Site Infection Prevention Collaborative MCIC March 2006.

26.2

10

22.6

6.2 6.32.2 2.7

9.3

14.5

40.7

50.7

73.3

79.5

85.888

90.7

0

20

40

60

80

100

Hours After Surgery End Time

Per

cent

0

20

40

60

80

100

Cum

ulat

ive

Per

cent

Discontinuation of Antibiotics

Patients were excluded from the denominator of this performance measure if there was any documentation of an infection during surgery or in the first 48 hours after surgery.

Bratzler DW, Houck PM, et al. Arch Surg 205:140:174-182

Page 33: Surgical Site Infection Prevention Collaborative MCIC March 2006.

SPECIAL CONSIDERATION: MORBID OBESITY

• Cefazolin 1 gram is not the correct dose for everyone– At incision and closure

1g , blood and tissue levels all lower than “normal” weight

– Below MIC for gram pos cocci and gram neg rods

• Cefazolin 2gm good blood and tissue levels

• Wound infection rates from 16.5% to 5.1%

Forse et al:surgery 1989:106,751-767

Page 34: Surgical Site Infection Prevention Collaborative MCIC March 2006.

CONCLUSIONS

• Must be familiar with principles of prophylaxis and CDC recommendations

• Morbidly obese patients should receive larger doses of antibiotics

Page 35: Surgical Site Infection Prevention Collaborative MCIC March 2006.

CONCLUSIONS:Beyond CDC

• Maintenance of normothermia maybe important (Level II)

• Glucose control perioperatively

Page 36: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Improving Safety and Quality:Five Step Model for Improvement

Page 37: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Why do we need to improve care?

In U.S. Healthcare system

• 44,000- 98,000 preventable deaths

• $50 billion in total costs

Similar results in UK and Australia

IOM report “To err is human”

Page 38: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Why do we need to improve care?

• Patients – Do the right thing!

• Purchasers – Leapfrog group

• Insurers

• Regulators – JCAHO ICU measurement set– CMS surgical care improvement project

Page 39: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Outline

• Review 5 step model for improvement

• Provide practical examples

• How will we prevent SSI?

Page 40: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Model to Improve

• Pick an important clinical area• Identify what should we do?

– principles of evidence-based medicine

• Measure if you are doing it• Ensure patients get what they should

– education– create redundancy– reduce complexity

• Evaluate whether outcomes are improved

Page 41: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Important Clinical Areas

• Eliminating CR-BSIs

• Ventilator Associated Pneumonia

• Sepsis Bundle

• Perioperative Beta Blockers

• VTE Prophylaxis

• Decreasing SSI

Page 42: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Model to Improve

• Pick an important clinical area• Identify what should we do?

– principles of evidence-based medicine

• Measure if you are doing it• Ensure patients get what they should

– education– create redundancy– reduce complexity

• Evaluate whether outcomes are improved

Page 43: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Model to Improve

• Pick an important clinical area• Identify what should we do?

– principles of evidence-based medicine

• Measure if you are doing it• Ensure patients get what they should

– education– create redundancy– reduce complexity

• Evaluate whether outcomes are improved

Page 44: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Outcome vs. Process Measures• Process

– full barrier precautions– DVT and PUD prophylaxis– Appropriate abx timing

Adv/Disadvantages– short cycle– feedback meaningful– no risk-adjustment

• Outcome– mortality– catheter-related BSI – SSI

Adv/Disadvantages– long cycle– feedback difficult– important to patients

McGlynn, Jt Comm J Qual Improv 1988

Page 45: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Model to Improve

• Pick an important clinical area• Identify what should we do?

– principles of evidence-based medicine

• Measure if you are doing it• Ensure patients get what they should

– education– create redundancy– reduce complexity

• Evaluate whether outcomes are improved

Page 46: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Systems Approach

• Every system is perfectly designed to get the results that it gets

Berwick

• If you want to change performance you need to change the system

Page 47: Surgical Site Infection Prevention Collaborative MCIC March 2006.

All improvement is local: we can provide concepts; you need to design interventions

Page 48: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Science of Safety

• Accept that we will make mistakes

• Focus on systems, including interpersonal communication, rather than people

• Largest barrier is lack of awareness evidence exists

• Standardize to reduce complexity

• Create independent checks

Page 49: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Model to Improve

• Pick an important clinical area• Identify what should we do?

– principles of evidence-based medicine

• Measure if you are doing it• Ensure patients get what they should

– education– create redundancy– reduce complexity

• Evaluate whether outcomes are improved

Page 50: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Eliminating SSI• Apply best practices

– If hair is removed, use clippers– Appropriate antibiotics

• Choice• Timing• Discontinuation

– Perioperative normothermia– Glycemic control

• Decrease complexity• Create redundancy

Page 51: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Tips for success• Engage

– Make the problem real– Publicly commit that harm is untenable

• Educate• Execute

– Culture, complexity and redundancy – Regular team meetings

• Evaluate – Measurement and feedback – Recognition and visibility– CELEBRATE SUCCESS !

Page 52: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Engage

– Make the problem real• Share local infection rates

• Share local compliance with process measures

• Share a story of a patient with SSI– (????) Have the patient share their story

– Publicly commit that harm is untenable• Institutional commitment

• Champions within the OR, within the teams, within the departments involved

Page 53: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Tips for success• Engage

– Make the problem real– Publicly commit that harm is untenable

• Educate• Execute

– Culture, complexity and redundancy – Regular team meetings

• Evaluate – Measurement and feedback – Recognition and visibility– CELEBRATE SUCCESS !

Page 54: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Educate

• Develop an educational plan to reach ALL members of the caregiver team– Use this power point or use you own local

experts – Educate on the evidence based practices AND

the data collection plan and other steps of the process.

• Use posters to educate the teams about the evidence-based process measures

Page 55: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Perioperative SSI Process Measures

Quality Indicator Numerator Denominator

Appropriate antibiotic choice Number of patients who received the appropriate prophylactic antibiotic

All patients for whom prophylactic antibiotics are indicated

Appropriate timing of prophylactic antibiotics

Number of patients who received the prophylactic antibiotic within 60 minutes prior to incision

All patients for whom prophylactic antibiotics are indicated

Appropriate discontinuation of antibiotics

Number of patients who received prophylactic antibiotics and had them discontinued in 24 hours

All patients who received prophylactic antibiotics

Appropriate hair removal Number of patients who did not have hair removed or who had hair removed with clippers

All surgical patients

Perioperative normothermia Number of patients with postoperative temperature ≥36.0oC

Patients undergoing colon surgery (Optional: All patients)

Perioperative glycemic control Number of cardiac surgery patients with glucose control at 6AM pod 1

Patients undergoing cardiac surgery

Page 56: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Perioperative SSI Process Measures Data collection plan

• How the process measures will be collected on ALL patients at the time of the surgical procedure

• The responsibility of all of the team members

Page 57: Surgical Site Infection Prevention Collaborative MCIC March 2006.

BSI poster

Page 58: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Tips for success• Engage

– Make the problem real– Publicly commit that harm is untenable

• Educate• Execute

– Culture, complexity and redundancy – Regular team meetings

• Evaluate – Measurement and feedback – Recognition and visibility– CELEBRATE SUCCESS !

Page 59: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Execute• Culture

• Develop a culture of intolerance for infection• Reduce complexity of the process

• Checklists• Local antibiotic guidelines posted in ORs

• Redundancy• Add to briefing/debriefing checklist• Post reminders in the OR (White board)

• Regular team meetings• Develop a project plan

– One or two tasks a week• Identify who owns the steps of the process that works in your

environment

Page 60: Surgical Site Infection Prevention Collaborative MCIC March 2006.
Page 61: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Catheter Related Blood Stream Infection Checklist

• Before the procedure, did they: – Wash hands

– Sterilize procedure site

– Drape entire patient in a sterile fashion

• During the procedure, did they:

– Use sterile gloves, mask and sterile gown

– Maintain a sterile field

• Did all personnel assisting with procedure follow the above precautions

• Empowered nursing to stop the procedure if violation occurred

Page 62: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Tips for success• Engage

– Make the problem real– Publicly commit that harm is untenable

• Educate• Execute

– Culture, complexity and redundancy – Regular team meetings

• Evaluate – Measurement and feedback – Recognition and visibility– CELEBRATE SUCCESS !

Page 63: Surgical Site Infection Prevention Collaborative MCIC March 2006.
Page 64: Surgical Site Infection Prevention Collaborative MCIC March 2006.
Page 65: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Sample Reports:SSI Process Measures Over Time Compared

to Cohort

Quality Measure Your TeamOther Teams in

Collaborative

Composite 84% 85%

Appropriate Abx Selection 87% 95%

Appropriate Abx Timing 98% 96%

Appropriate Hair Removal 96% 95%

Prevention of Hypothermia 61% 57%

Page 66: Surgical Site Infection Prevention Collaborative MCIC March 2006.
Page 67: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Sample Reports:SSI Process Measures Over Time Compared

to CohortMCIC Perioperative Collaborative

Sample Report for SSI Process MeasuresPerformance Compared to Cohort

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Composite Appropriate AbxSelection

Appropriate AbxTiming

Appropriate HairRemoval

Prevention ofHypothermia

Quality Measure

Perc

en

t C

om

pli

an

ce

Your Team

Other Teams in Collaborative

Page 68: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Sample Reports:SSI rates Over Time Compared to Cohort

MCIC Perioperative Collaborative Quarterly SSI Rate Over Time Baseline to Third Quarter 2005

0.00

1.00

2.00

3.00

4.00

5.00

6.00

7.00

8.00

9.00

10.00

SS

I rate / 100 C

ases

Cohort

Your Team

Page 69: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Sample Reports:SSI rates Over Time Compared to CohortYour Team

Reporting Period # SSI CasesMedian SSI rate /

100 cases

Baseline 16 2533 6.32

Jan 05 - March 05 6 744 8.06

April 05 - June 05 2 637 3.14

July 05 - Sept 05 1 744 1.34

Oct 05 - Dec 05 1 546 1.83

All Teams in Cohort

Reporting Period # SSI CasesMedian SSI rate /

100 cases

Baseline 45 8900 5.06

Jan 05 - March 05 4 650 6.15

April 05 - June 05 8 1250 6.40

July 05 - Sept 05 6 1500 4.00

Oct 05 - Dec 05 3 1100 2.73

Page 70: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Tips for success• Engage

– Make the problem real– Publicly commit that harm is untenable

• Educate• Execute

– Culture, complexity and redundancy – Regular team meetings

• Evaluate – Measurement and feedback – Recognition and visibility– CELEBRATE SUCCESS !

Page 71: Surgical Site Infection Prevention Collaborative MCIC March 2006.

QI ProcessProcess # hospitals Baseline 4th quarter Difference

< 1hour 44 72 95 15

Selection 44 90 95 3.4

Normothermia 29 57 74 12

NOT Shaving 14 59 95 27

Oxygenation 8 75 94 18

Glucose control 5 46 54 18

Dellinger P et al. Am J Surg 2005;190;9-15

Page 72: Surgical Site Infection Prevention Collaborative MCIC March 2006.

QI Efforts

Dellinger P et al. Am J Surg 2005;190;9-15

Page 73: Surgical Site Infection Prevention Collaborative MCIC March 2006.

Will You Commit to Improve Quality?

• If not now, then when?

• If not this, then what?• If not you, then who?